REQUEST A DEMO
Total
USD $0.00
Search more companies

Moleculas Biologicas Biomolec CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Moleculas Biologicas Biomolec CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Moleculas Biologicas Biomolec CIA Ltda is an enterprise in Ecuador, with the main office in Cumbaya. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on September 27, 2013. It currently has a total number of 29 (2023) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 26.52% in 2023. There was a total growth of 17.26% in Moleculas Biologicas Biomolec CIA Ltda’s total assets over the same period. The enterprise’s net profit margin decreased by 3.65% in 2023.

Headquarters
Via Tanda 2410, Cc Plaza del Ranchi Bldg. , Floor 303
Cumbaya; Pichincha;

Contact Details: Purchase the Moleculas Biologicas Biomolec CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Moleculas Biologicas Biomolec CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Moleculas Biologicas Biomolec CIA Ltda report to view the information.
Registered Capital:
Purchase the Moleculas Biologicas Biomolec CIA Ltda report to view the information.
Incorporation Date:
September 27, 2013
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Moleculas Biologicas Biomolec CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
26.52%
Total operating revenue
26.52%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-21.22%
Total assets
17.26%
Total equity
1.42%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-3.65%
Return on Equity (ROE)
-4.9%
Quick Ratio
-0.5%
Cash Ratio
-0.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?